Skip to main content

WELLS FARGO & COMPANY/MN

Position in GNLX — GENELUX Corp

CIK 72971 SAN FRANCISCO, CA

Position in GNLX

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$5,408
-$14,146 QoQ
Shares Held
2,235
-50.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GNLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. GNLX ranks #309 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GNLX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,408 2,235
2025-12-31 $19,554 4,485
2025-09-30 $18,858 4,490
2025-06-30 $12,886 4,490
2025-03-31 $12,123 4,490
2024-12-31 $10,596 4,490
2024-09-30 $10,653 4,495
2024-06-30 $8,765 4,495
2024-03-31 $60,949 9,479
2023-12-31 $118,873 8,485
2023-09-30 $881,957 36,013
2023-06-30 $120,344 3,678
2023-03-31 $28,239 1,018